Endocrine system diseases and radiological diagnostics (sonography,contrast methods,sctinigraphy,ct, mri) advantages disadvantages indications Also include anatomy and physiology in very short

Reading File
Your request covers a full chapter. Here is the map and a short overview. Pick one topic and I'll go through it in depth with textbook sources and images.

Topic breakdown

  1. Endocrine anatomy and physiology (short summary)
  2. Imaging modalities: how each works, advantages, disadvantages
  3. Pituitary and hypothalamus (adenoma, prolactinoma, acromegaly, Cushing disease, hypopituitarism)
  4. Thyroid (goitre, nodules, Graves disease, thyroiditis, cancer)
  5. Parathyroid (hyperparathyroidism, adenoma localisation)
  6. Adrenal (incidentaloma, Conn, Cushing, pheochromocytoma, adrenal insufficiency)
  7. Pancreatic endocrine tumours (insulinoma, gastrinoma, MEN syndromes)
  8. Gonads, bone and others (PCOS, osteoporosis, rickets)
  9. Imaging selection summary table: which test for which organ

Short overview

Anatomy and physiology
  • The hypothalamus and pituitary control the other glands. The anterior pituitary releases GH, PRL, ACTH, TSH, FSH and LH. The posterior pituitary releases ADH and oxytocin.
  • The thyroid sits in front of the trachea. It makes T3 and T4, which set metabolic rate. C cells make calcitonin.
  • The four parathyroids sit behind the thyroid. They make PTH, which raises serum calcium.
  • The adrenals sit above the kidneys. The cortex makes aldosterone, cortisol and androgens. The medulla makes catecholamines.
  • The endocrine pancreas (islets) makes insulin and glucagon. The gonads make sex steroids.
  • Most axes work by negative feedback.
Imaging modalities (general)
ModalityAdvantagesDisadvantagesMain endocrine indications
UltrasoundNo radiation, cheap, real-time, guides FNAOperator dependent, poor for deep or retrosternal lesions, limited in obese patientsThyroid nodules and goitre, parathyroid adenoma, thyroid FNA guidance, ovaries and testes
Contrast methods (CT or X-ray with contrast, angiography, venous sampling)Show vascular detail and function. Sampling localises hormone source.Iodinated contrast can worsen thyrotoxicosis and affects the kidneys. Radiation. Invasive.Adrenal vein sampling (Conn), inferior petrosal sinus sampling (Cushing), selective venous sampling for parathyroid or pancreatic tumours
Scintigraphy (I-123, Tc-99m pertechnetate, sestamibi, MIBG, octreotide)Shows function as well as structure, whole-body surveyPoor anatomical resolution, radiation dose, long acquisition, costThyroid nodule function (hot or cold), Graves disease, ectopic thyroid, parathyroid adenoma (sestamibi), pheochromocytoma (MIBG), neuroendocrine tumours (octreotide, DOTATATE PET)
CTFast, excellent for bone and calcification, high resolution for adrenal and pancreasRadiation, contrast risks, poor soft-tissue contrast in the sellaAdrenal masses (attenuation and washout), pancreatic NETs, retrosternal goitre, thyroid cancer staging
MRIBest soft-tissue contrast, no radiation, multiplanarCostly, long scan, contraindicated with some implants, claustrophobiaPituitary and sella (first choice), adrenal characterisation, pancreatic NETs, hypothalamic lesions
I haven't yet pulled textbook passages, so none of this is cited. The deep-dive will use the library.
Asking for Preferences

Which topic should I cover in detail first?

Your request covers a full chapter. Here is the map and a short overview. Pick one topic and I'll go through it in depth with textbook sources and images.

Topic breakdown

  1. Endocrine anatomy and physiology (short summary)
  2. Imaging modalities: how each works, advantages, disadvantages
  3. Pituitary and hypothalamus (adenoma, prolactinoma, acromegaly, Cushing disease, hypopituitarism)
  4. Thyroid (goitre, nodules, Graves disease, thyroiditis, cancer)
  5. Parathyroid (hyperparathyroidism, adenoma localisation)
  6. Adrenal (incidentaloma, Conn, Cushing, pheochromocytoma, adrenal insufficiency)
  7. Pancreatic endocrine tumours (insulinoma, gastrinoma, MEN syndromes)
  8. Gonads, bone and others (PCOS, osteoporosis, rickets)
  9. Imaging selection summary table: which test for which organ

Short overview

Anatomy and physiology
  • The hypothalamus and pituitary control the other glands. The anterior pituitary releases GH, PRL, ACTH, TSH, FSH and LH. The posterior pituitary releases ADH and oxytocin.
  • The thyroid sits in front of the trachea. It makes T3 and T4, which set metabolic rate. C cells make calcitonin.
  • The four parathyroids sit behind the thyroid. They make PTH, which raises serum calcium.
  • The adrenals sit above the kidneys. The cortex makes aldosterone, cortisol and androgens. The medulla makes catecholamines.
  • The endocrine pancreas (islets) makes insulin and glucagon. The gonads make sex steroids.
  • Most axes work by negative feedback.
Imaging modalities (general)
ModalityAdvantagesDisadvantagesMain endocrine indications
UltrasoundNo radiation, cheap, real-time, guides FNAOperator dependent, poor for deep or retrosternal lesions, limited in obese patientsThyroid nodules and goitre, parathyroid adenoma, thyroid FNA guidance, ovaries and testes
Contrast methods (CT or X-ray with contrast, angiography, venous sampling)Show vascular detail and function. Sampling localises hormone source.Iodinated contrast can worsen thyrotoxicosis and affects the kidneys. Radiation. Invasive.Adrenal vein sampling (Conn), inferior petrosal sinus sampling (Cushing), selective venous sampling for parathyroid or pancreatic tumours
Scintigraphy (I-123, Tc-99m pertechnetate, sestamibi, MIBG, octreotide)Shows function as well as structure, whole-body surveyPoor anatomical resolution, radiation dose, long acquisition, costThyroid nodule function (hot or cold), Graves disease, ectopic thyroid, parathyroid adenoma (sestamibi), pheochromocytoma (MIBG), neuroendocrine tumours (octreotide, DOTATATE PET)
CTFast, excellent for bone and calcification, high resolution for adrenal and pancreasRadiation, contrast risks, poor soft-tissue contrast in the sellaAdrenal masses (attenuation and washout), pancreatic NETs, retrosternal goitre, thyroid cancer staging
MRIBest soft-tissue contrast, no radiation, multiplanarCostly, long scan, contraindicated with some implants, claustrophobiaPituitary and sella (first choice), adrenal characterisation, pancreatic NETs, hypothalamic lesions
I haven't yet pulled textbook passages, so none of this is cited. The deep-dive will use the library.
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Searching PubMed

"thyroid nodule"[MeSH Terms] AND "ultrasonography"[MeSH Terms]

Searching Images

pituitary macroadenoma MRI coronal

This composite diagnostic image panel displays a pituitary macroadenoma through multi-modal imaging. Panels A (axial) and B (coronal) are non-contrast brain CT scans showing a soft tissue mass within the sella turcica with associated bony remodeling of the skull base. Panels C (sagittal) and D (coronal) are T1-weighted contrast-enhanced MRI scans, providing superior soft tissue resolution. The MRI demonstrates a 1.8 x 1.6 x 1.6 cm heterogeneously enhancing lesion predominantly located in the right aspect of the pituitary gland. Key mass effects include a distinct leftward deviation of the pituitary stalk and possible invasion into the medial portion of the right cavernous sinus. The imaging illustrates the diagnostic criteria for a pituitary macroadenoma, specifically highlighting its relationship with adjacent neurovascular structures like the optic chiasm and cavernous sinuses. This is a critical educational resource for neuroradiology and endocrinology, demonstrating the utility of MRI over CT in evaluating sellar and suprasellar pathology.

This composite diagnostic image panel displays a pituitary macroadenoma through multi-modal imaging. Panels A (axial) and B (coronal) are non-contrast brain CT scans showing a soft tissue mass within the sella turcica with associated bony remodeling of the skull base. Panels C (sagittal) and D (coronal) are T1-weighted contrast-enhanced MRI scans, providing superior soft tissue resolution. The MRI demonstrates a 1.8 x 1.6 x 1.6 cm heterogeneously enhancing lesion predominantly located in the right aspect of the pituitary gland. Key mass effects include a distinct leftward deviation of the pituitary stalk and possible invasion into the medial portion of the right cavernous sinus. The imaging illustrates the diagnostic criteria for a pituitary macroadenoma, specifically highlighting its relationship with adjacent neurovascular structures like the optic chiasm and cavernous sinuses. This is a critical educational resource for neuroradiology and endocrinology, demonstrating the utility of MRI over CT in evaluating sellar and suprasellar pathology.

This composite of magnetic resonance imaging (MRI) of the brain and sella turcica demonstrates a large pituitary macroadenoma. The upper row features contrast-enhanced images in coronal, axial, and sagittal planes, revealing a well-circumscribed, enhancing ovoid mass measuring approximately 2.3 x 1.7 x 2.2 cm. The tumor is centered in the sella turcica with significant suprasellar extension into the suprasellar cistern and lateral invasion into the bilateral cavernous sinuses. In the coronal view, the mass is seen abutting the optic chiasm. The bottom row displays corresponding post-operative MRI views (coronal, axial, and sagittal), illustrating the surgical cavity following transsphenoidal resection, with an absence of the previously noted macroadenoma. Key anatomical landmarks visible include the sphenoid sinus, internal carotid arteries within the cavernous sinuses, and the brainstem. These images are diagnostic for a TSH-secreting pituitary macroadenoma in the context of central hyperthyroidism, highlighting the importance of pre-operative mapping of neurovascular involvement.

This composite of magnetic resonance imaging (MRI) of the brain and sella turcica demonstrates a large pituitary macroadenoma. The upper row features contrast-enhanced images in coronal, axial, and sagittal planes, revealing a well-circumscribed, enhancing ovoid mass measuring approximately 2.3 x 1.7 x 2.2 cm. The tumor is centered in the sella turcica with significant suprasellar extension into the suprasellar cistern and lateral invasion into the bilateral cavernous sinuses. In the coronal view, the mass is seen abutting the optic chiasm. The bottom row displays corresponding post-operative MRI views (coronal, axial, and sagittal), illustrating the surgical cavity following transsphenoidal resection, with an absence of the previously noted macroadenoma. Key anatomical landmarks visible include the sphenoid sinus, internal carotid arteries within the cavernous sinuses, and the brainstem. These images are diagnostic for a TSH-secreting pituitary macroadenoma in the context of central hyperthyroidism, highlighting the importance of pre-operative mapping of neurovascular involvement.

Searching Images

Graves disease thyroid scintigraphy diffuse uptake

A multi-panel medical figure illustrating diagnostic findings and clinical progression of Graves' disease. Panel (A) displays a Technetium-99m (Tc99) thyroid scintigraphy scan showing a gland with diffuse increased radionuclide uptake, particularly prominent in the inferior left lobe, characteristic of hyperthyroidism. Panel (B) is a grayscale thyroid ultrasound revealing a heterogeneous echotexture of the parenchyma without discrete nodules. Panel (C) utilizes Doppler sonography to demonstrate diffuse hypervascularity (thyroid inferno), a hallmark of active Graves' disease. Panel (D) is a line graph tracking thyroid function tests over 11 months, plotting fT3 (pg/mL) and fT4 (ng/dL) against TSH (mIU/L). The timeline shows initial thyrotoxicosis, stabilization on thiamazole, and a subsequent relapse in hormone levels following a SARS-CoV-2 infection marked by an arrow. This composite serves as an educational resource for correlating nuclear medicine, ultrasonography, and longitudinal biochemical monitoring in autoimmune thyroid disorders.

A multi-panel medical figure illustrating diagnostic findings and clinical progression of Graves' disease. Panel (A) displays a Technetium-99m (Tc99) thyroid scintigraphy scan showing a gland with diffuse increased radionuclide uptake, particularly prominent in the inferior left lobe, characteristic of hyperthyroidism. Panel (B) is a grayscale thyroid ultrasound revealing a heterogeneous echotexture of the parenchyma without discrete nodules. Panel (C) utilizes Doppler sonography to demonstrate diffuse hypervascularity (thyroid inferno), a hallmark of active Graves' disease. Panel (D) is a line graph tracking thyroid function tests over 11 months, plotting fT3 (pg/mL) and fT4 (ng/dL) against TSH (mIU/L). The timeline shows initial thyrotoxicosis, stabilization on thiamazole, and a subsequent relapse in hormone levels following a SARS-CoV-2 infection marked by an arrow. This composite serves as an educational resource for correlating nuclear medicine, ultrasonography, and longitudinal biochemical monitoring in autoimmune thyroid disorders.

This diagnostic nuclear medicine image shows a Technetium-99m (99mTc) pertechnetate scintigraphy of the thyroid gland in the anterior view. The scan demonstrates markedly increased and diffuse radiotracer uptake throughout both the right and left lobes of the thyroid gland, which maintains its characteristic butterfly shape without evidence of focal nodules or cold zones. The intense, homogenous distribution is a classic hallmark of Graves' disease, indicating global hyperfunction. For comparison, normal physiologic uptake is visible in the salivary glands in the upper portion of the field, though its intensity is significantly lower than that of the hypermetabolic thyroid gland. This imaging modality is essential for differentiating etiologies of thyrotoxicosis, distinguishing diffuse hyperfunction from destructive thyroiditis or toxic multinodular goiter.

This diagnostic nuclear medicine image shows a Technetium-99m (99mTc) pertechnetate scintigraphy of the thyroid gland in the anterior view. The scan demonstrates markedly increased and diffuse radiotracer uptake throughout both the right and left lobes of the thyroid gland, which maintains its characteristic butterfly shape without evidence of focal nodules or cold zones. The intense, homogenous distribution is a classic hallmark of Graves' disease, indicating global hyperfunction. For comparison, normal physiologic uptake is visible in the salivary glands in the upper portion of the field, though its intensity is significantly lower than that of the hypermetabolic thyroid gland. This imaging modality is essential for differentiating etiologies of thyrotoxicosis, distinguishing diffuse hyperfunction from destructive thyroiditis or toxic multinodular goiter.

Endocrine diseases and imaging: anatomy, physiology, modalities, indications

1. Anatomy and physiology (very short)

GlandLocationMain hormonesMain role
HypothalamusDiencephalonTRH, CRH, GnRH, GHRH, somatostatin, dopamineControls the pituitary
Anterior pituitarySella turcicaGH, PRL, ACTH, TSH, FSH, LHGrowth, lactation, and control of the thyroid, adrenals and gonads
Posterior pituitarySella turcicaADH, oxytocinWater balance, uterine contraction and milk ejection
ThyroidAnterior neck, below the larynxT3, T4, calcitoninMetabolic rate, calcium (calcitonin)
Parathyroids (usually 4)Behind the thyroid; ectopic glands occurPTHRaises serum calcium
Adrenal cortexAbove the kidneysCortisol, aldosterone, androgensStress response, BP and Na/K balance
Adrenal medullaAbove the kidneysAdrenaline, noradrenalineFight or flight
Pancreatic isletsPancreasInsulin, glucagon, somatostatinGlucose control
GonadsPelvis or scrotumOestrogen, progesterone, testosteroneReproduction and secondary sex characteristics
Most axes work by negative feedback (hypothalamus, then pituitary, then target gland). Disease is either hormone excess, hormone deficiency, or mass effect. Mass effect includes a goitre compressing the trachea or a pituitary tumour causing bitemporal hemianopia.

2. Imaging modalities: advantages, disadvantages, indications

Ultrasound (US)

  • Advantages:
    • No radiation, cheap and widely available.
    • Real-time imaging, with Doppler for vascularity.
    • Guides fine needle aspiration (FNA).
    • More detailed than scintigraphy for thyroid nodules and the most cost-effective way to screen for thyroid adenoma. It also finds extra nodules in 20 to 48% of patients referred with a "solitary" nodule (K J Lee's Essential Otolaryngology, Endocrine section).
  • Disadvantages:
    • Operator dependent.
    • Cannot see retrosternal extension or deep structures well, and is limited in obese patients.
    • Gives no functional information.
  • Indications:
    • Thyroid nodule, goitre and thyroiditis.
    • Neck lymph nodes in thyroid cancer.
    • Parathyroid adenoma localisation (first-line with scintigraphy).
    • Ovarian (PCOS) and testicular pathology.
    • FNA guidance.
    • Doppler "thyroid inferno" suggests Graves disease.

Contrast methods

These include contrast CT, angiography and selective venous sampling.
  • Advantages:
    • Show vascular anatomy.
    • Sampling localises the hormone source. Inferior petrosal sinus sampling distinguishes pituitary from ectopic ACTH. Adrenal vein sampling distinguishes unilateral from bilateral aldosterone excess. Selective venous sampling localises parathyroid and pancreatic tumours.
  • Disadvantages:
    • Invasive, with technical failure and complications.
    • Iodinated contrast can trigger thyrotoxicosis in nodular goitre, and it delays radioiodine uptake and therapy for weeks.
    • Contrast nephropathy and allergy.
    • Radiation.
  • Indications: Biochemically proven disease with negative or equivocal cross-sectional imaging. This applies to Cushing disease with a negative pituitary MRI (Bailey and Love, Radiological section), primary aldosteronism when surgery is considered, and occult hyperparathyroidism or insulinoma.

Scintigraphy and nuclear medicine

  • Tracers:
    • Tc-99m pertechnetate, or I-123/I-131 (Sabiston, Nuclear Scintigraphy).
    • Tc-99m sestamibi for parathyroid.
    • MIBG for pheochromocytoma and paraganglioma.
    • Octreotide or Ga-68 DOTATATE PET-CT for neuroendocrine tumours (NETs).
    • FDG-PET for dedifferentiated thyroid cancer.
  • Advantages:
    • Shows function, not just structure.
    • Whole-body survey for metastases or multifocal disease.
    • Single-session localisation of ectopic tissue (retrosternal goitre, ectopic parathyroid).
  • Disadvantages:
    • Low spatial resolution.
    • Radiation dose, and long scan times.
    • False positives, for example sestamibi uptake in thyroid nodules, carcinomas and lymph nodes (Fischer's Mastery of Surgery).
    • Contraindicated or restricted in pregnancy and breastfeeding.
    • Interference from iodine, drugs or recent contrast.
    • Sestamibi is less sensitive for small (<500 mg) glands.
  • Indications:
    • Hyperthyroidism with a nodule. Scintigraphy establishes solitary versus multiple hyperfunctioning nodules (Plummer disease) and is paired with US (Sabiston, Ultrasound Evaluation of Thyroid Nodules).
    • Graves versus thyroiditis: diffuse high uptake in Graves, low uptake in destructive thyroiditis.
    • Ectopic thyroid and thyroid cancer remnant or metastases after surgery.
    • Parathyroid adenoma: sestamibi SPECT/CT, sometimes with dual-isotope subtraction.
    • Pheochromocytoma and paraganglioma (MIBG).
    • Neuroendocrine tumours (SSTR PET).
Tc-99m scan in Graves disease, diffuse uptake
Graves disease: diffuse, homogeneous high uptake in both lobes on Tc-99m pertechnetate scintigraphy.

CT

  • Advantages:
    • Fast, widely available, with excellent spatial resolution.
    • Best for bone, calcification and the lungs.
    • Measures density (Hounsfield units) and contrast washout.
    • Good for adrenals, pancreas and mediastinum.
    • 4D-CT localises parathyroid adenomas.
  • Disadvantages:
    • Ionising radiation.
    • Iodinated contrast has the thyroid and renal problems described above.
    • Poor soft-tissue contrast in the sella compared with MRI.
    • Dental or bone artefact at the skull base.
  • Indications:
    • Adrenal mass characterisation. Benign adenomas are low density (<10 HU), while carcinomas tend to be hyperattenuating (>18 HU), heterogeneous and irregular (Bailey and Love, Investigation; Schwartz, Adrenal Incidentaloma).
    • Pancreatic NETs.
    • Retrosternal goitre and tracheal compression.
    • Staging of thyroid cancer (non-iodinated contrast if radioiodine is planned).
    • Ectopic ACTH search: thorax, abdomen and pelvis.
    • Parathyroid 4D-CT.
    • Pituitary only if MRI is contraindicated, in which case it shows bony remodelling.

MRI

  • Advantages:
    • Best soft-tissue contrast.
    • No ionising radiation.
    • Multiplanar imaging.
    • Gadolinium is not nephrotoxic at standard doses and does not affect thyroid function.
    • Chemical-shift sequences characterise adrenal adenomas (lipid-rich).
  • Disadvantages:
    • Expensive, with long scan times and motion artefact.
    • Contraindicated with some devices and implants, and claustrophobia is an issue.
    • Less sensitive for calcification.
    • Limited lung and bone detail.
    • Gadolinium caution in severe renal failure.
  • Indications:
    • Pituitary and hypothalamic region.
      • MRI is the preferred method for pituitary anatomy. The normal gland is under 1 cm in height, and microadenomas appear hypointense on T1 (Goldman-Cecil, Diagnosis; K J Lee's, Radiograph Studies).
      • Used for adenoma, craniopharyngioma, Rathke cleft cyst, hypophysitis and stalk lesions. Look for optic chiasm compression and cavernous sinus invasion.
    • Adrenal masses, for example in pregnancy, children, or when CT is indeterminate.
    • Pancreatic NETs and liver metastases.
    • Parathyroid, as an alternative localisation tool.
    • Neck, for local extension of thyroid cancer.
Pituitary macroadenoma on CT and MRI
Pituitary macroadenoma: CT (A, B) shows the sellar mass and bone remodelling. Contrast MRI (C, D) shows the lesion, stalk deviation and possible cavernous sinus invasion.

3. Disease-by-disease: best test

OrganDiseaseFirst-lineNext / problem solver
PituitaryAdenoma (prolactinoma, acromegaly, Cushing disease, non-functioning)Pituitary-protocol MRICT if MRI is contraindicated; inferior petrosal sinus sampling for ACTH source
ThyroidNodule, goitreUS, then FNAScintigraphy if TSH is suppressed; CT/MRI for retrosternal extent
ThyroidGraves diseaseBiochemistry plus US (Doppler)Scintigraphy: diffuse uptake
ThyroidThyroiditisUSScintigraphy: low uptake
ThyroidCancerUS plus FNACT/MRI for staging; I-131 whole-body scan; FDG-PET if radioiodine-refractory
ParathyroidPrimary hyperparathyroidismUS plus sestamibi SPECT/CT4D-CT, MRI, venous sampling
AdrenalIncidentalomaUnenhanced CT (HU)Washout CT, chemical-shift MRI, FDG-PET
AdrenalConn syndromeCTAdrenal vein sampling
AdrenalCushing syndromeBy source: pituitary MRI, adrenal CT, thorax/abdomen CTGa-68 SSTR PET-CT for ectopic ACTH (Bailey and Love)
AdrenalPheochromocytomaCT or MRI (T2 bright)MIBG or DOTATATE for multifocal or metastatic disease
PancreasInsulinoma, gastrinoma, other NETsMultiphase CT/MRIEndoscopic US, SSTR PET-CT, venous sampling
BoneOsteoporosis, ricketsDXA, X-rayCT/MRI for complications

4. Key principles

  • Biochemistry first, imaging second. Image only after the hormonal diagnosis is confirmed, because incidentalomas are common.
  • Avoid iodinated contrast before radioiodine scanning or therapy, and in thyrotoxic nodular goitre.
  • Thyroid: US plus FNA for structure, scintigraphy for function.
  • Pituitary: MRI.
  • Adrenal: CT density, with MRI as the problem solver.
  • Parathyroid: US plus sestamibi SPECT/CT.
  • Neural crest and neuroendocrine tumours: MIBG or SSTR PET.
Recent evidence check: A 2026 meta-analysis of contrast-enhanced ultrasound (PMID 42262145) and a 2024 meta-analysis combining CEUS and elastography (PMID 38824246) assess newer US techniques for thyroid nodule characterisation. They add to the standard US plus FNA approach and do not contradict the textbook content. I did not read their full texts, so I can't give pooled accuracy figures.
I can go deeper on any single organ, add exam-style questions, or turn this into a slide deck or Word document.
This is a shared conversation. Sign in to Orris to start your own chat.